Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581
NCT02567370
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia or Schizoaffective Disorder
Interventions
DRUG:
AMG 581
DRUG:
Placebo
Sponsor
Amgen